AVAXIM is a vaccine used to prevent hepatitis A, a serious liver disease caused by the hepatitis A virus (HAV). It is typically administered as an injection into the muscle and is recommended for individuals who are at increased risk of HAV infection or for those who wish to obtain immunity against this virus. AVAXIM works by stimulating the body's immune system to produce antibodies against hepatitis A, providing active immunity and protecting the vaccinated individual from the virus. The vaccine is known for its effectiveness and is used in various healthcare settings worldwide to control the spread of hepatitis A. It is suitable for both adults and children, with specific dosages and schedules depending on the age and health status of the recipient.